MSI Claw 8 AI+
TechRadar's personal favorite with a huge battery and consistent MSI firmware updates. A proven, dependable daily driver.
Consolidated from 5 independent outlets
Where the cited sources landed, as we read them
- 3 positive sources
Pros & cons
- ✓ Immersive display, long battery life, and dependable performance
- ✓ Large battery
- ✓ MSI's steady firmware updates for the Claw line
- ✓ Genuinely good multi-year ownership profile
- ✓ The efficiency standout among Windows handhelds
- ✗ Raw frame rates trail the AMD flagships
- ✗ Superseded by a much stronger CPU in the newer Claw 8 EX
- ✗ Heavier build
- ✗ Higher price
The sources behind this ranking
We searched the web and YouTube for what has been published about this product, then read the articles, video transcripts and comments we found. 2 outlets wouldn't let us check their links. We quote no words from these sources, so each row shows only where we placed it.
Evidence 3 articles, 1 video review and 1 community source
3 positive sources
2 stance not read sources
Frequently asked questions
It ranks #4 of 15 on our handheld gaming PCs tier list, in B tier. That placement draws on 5 independent outlets.
None of the 3 sources with a clear view is critical of it. Raw frame rates trail the AMD flagships. Superseded by a much stronger CPU in the newer Claw 8 EX. Heavier build. Higher price.
Ranked nearby in Handheld Gaming PCs
S tier #1 Asus ROG Xbox Ally X
S tier #2 Steam Deck OLED
A tier #3 MSI Claw 8 EX AI+
B tier #5 2 of 8 research runs entered this as a product to avoid rather than a pick. Asus ROG Ally X
C tier #6 OneXPlayer
C tier #7 1 of 3 research runs entered this as a product to avoid rather than a pick. Steam Deck LCD
C tier #8 1 of 6 research runs entered this as a product to avoid rather than a pick. Asus ROG Xbox Ally
C tier #9 2 of 6 research runs entered this as a product to avoid rather than a pick. Lenovo Legion Go S (Z1 Extreme)
F tier #14 2 of 3 research runs entered this as a product to avoid rather than a pick. Asus ROG Ally
F tier #15 2 of 6 research runs entered this as a product to avoid rather than a pick.